Type 2 diabetes mellitus and Alzheimer’s disease

Cited by (315)

Items 101–200 of 315

1. The Characteristics of Diabetic Residents in European Nursing Homes: Results from the SHELTER Study
   Katarzyna E. Szczerbińska, Eva Topinková, Piotr Brzyski, Henriëtte G. van der Roest, Tomáš Richter, Harriet Finne‐Soveri, Michael Dieter Denkinger, Jacob Gindin, Graziano Onder, Roberto Bernabei · 2014 · Journal of the American Medical Directors Association
2. Agrimonia pilosa Ledeb., Cinnamomum cassia Blume, and Lonicera japonica Thunb. protect against cognitive dysfunction and energy and glucose dysregulation by reducing neuroinflammation and hippocampal insulin resistance in β-amyloid-infused rats
   Sunmin Park, Suna Kang, Da Sol Kim, Bo Reum Moon · 2016 · Nutritional Neuroscience
3. The Metabolic Response to a Low Amino Acid Diet is Independent of Diet-Induced Shifts in the Composition of the Gut Microbiome
   Heidi H. Pak, Nicole E. Richardson, Cara L. Green, Jacqueline A. Brinkman, Deyang Yu, Jay L. Tomasiewicz, Shany E. Yang, Colin Boyle, Elizabeth N. Konon, Irene M. Ong et al. · 2019 · Scientific Reports
4. Effect of diabetes on caregiver burden in an observational study of individuals with Alzheimer’s disease
   Jérémie Lebrec, Haya Ascher‐Svanum, Yun-Fei Chen, Catherine C. Reed, Kristin Kahle‐Wrobleski, Ann Marie Hake, Joel Raskin, Ebrahim Khalil Naderali, Dara Schuster, Robert J. Heine et al. · 2016 · BMC Geriatrics
5. Docosahexaenoic Acid Increases the Potency of Soluble Epoxide Hydrolase Inhibitor in Alleviating Streptozotocin-Induced Alzheimer’s Disease-Like Complications of Diabetes
   Rohit Pardeshi, Nityanand B. Bolshette, Kundlik Gadhave, Mohammad Arfeen, Sahabuddin Ahmed, Rohitash Jamwal, Bruce D. Hammock, Mangala Lahkar, Sumanta Kumar Goswami · 2019 · Frontiers in Pharmacology
6. Neuroprotective and memory-enhancing effects of methanolic leaf extract of Peristrophe bicalyculata in rat model of type 2 diabetes mellitus.
   Anoka Ayembe Njan, Francisca O. Adenuga, Abayomi Mayowa Ajayi, Olasubomi F Sotunde, Mary Olufunmilayo Ologe, Solomon O. Olaoye, Ozlem Nazan Erdogan, Olugbenga E. Iwalewa · 2020 · Heliyon
7. Apomorphine Therapy for Neuronal Insulin Resistance in a Mouse Model of Alzheimer’s Disease
   Norimichi Nakamura, Yasumasa Ohyagi, Tomohiro Imamura, Yuki T. Yanagihara, Kyoko Iinuma, Naoko Soejima, Hiroyuki Murai, Ryo Yamasaki, Jun‐ichi Kira · 2017 · Journal of Alzheimer s Disease
8. JNK signaling pathway regulates sorbitol-induced Tau proteolysis and apoptosis in SH-SY5Y cells by targeting caspase-3
   Marta Olivera‐Santa Catalina, Montaña Caballero Bermejo, Ricardo Argent, Juan C. Alonso, Francisco Centeno, M. J. Varas Lorenzo · 2017 · Archives of Biochemistry and Biophysics
9. Association between serum homocysteine level and cognitive function in middle-aged type 2 diabetes mellitus patients
   Johanda Damanik, Andre Mayza, Andhika Rachman, Rani Sauriasari, Melly Kristanti, Putri Syahida Agustina, Alexander Randy Angianto, Pukovisa Prawiroharjo, Em Yunir · 2019 · PLoS ONE
10. Cognitive deficits and Alzheimer-like neuropathological impairments during adolescence in a rat model of type 2 diabetes mellitus
    Wang Li, Li Jin, Yi-Pei Li, Qiong Feng, Li Ren, Fang Wang, Guo-Jia Bo · 2018 · Neural Regeneration Research
11. Exploitation of Quercetin’s Antioxidative Properties in Potential Alternative Therapeutic Options for Neurodegenerative Diseases
    Viorica Rarinca, Mircea Nicoară, Dorel Ureche, Alin Stelian Ciobica · 2023 · Antioxidants
12. Cdk5-mediated oligodendrocyte myelin breakdown and neuroinflammation: Implications for the link between Type 2 Diabetes and Alzheimer's disease
    Sangita Chowdhury Paul, Juhi Bhardwaj, Balachandran Krishnamma Binukumar · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
13. Hyperglycemia induced the Alzheimer’s proteins and promoted loss of synaptic proteins in advanced-age female Goto-Kakizaki (GK) rats
    Hiranya Pintana, Nattayaporn Apaijai, Sasiwan Kerdphoo, Wasana Pratchayasakul, Jirapas Sripetchwandee, Panan Suntornsaratoon, Narattaphol Charoenphandhu, Nipon Chattipakorn, Siriporn Chaisin Chattipakorn · 2017 · Neuroscience Letters
14. Effect of pioglitazone and simvastatin in lipopolysaccharide-induced amyloidogenesis and cognitive impairment in mice: possible role of glutamatergic pathway and oxidative stress
    Sara T. Ekladious, Nesrine S. El Sayed · 2018 · Behavioural Pharmacology
15. Zonisamide Ameliorates Cognitive Impairment by Inhibiting ER Stress in a Mouse Model of Type 2 Diabetes Mellitus
    Yong-xiang He, Qiying Shen, Jiahui Tian, Qian Wu, Xue Ying Qin, Guiping Zhang, Wei Wei, Yinghua Liu · 2020 · Frontiers in Aging Neuroscience
16. Low education and lack of spousal relationship are associated with dementia in older adults with diabetes mellitus in Nigeria
    Abdulkareem Jika Yusuf, Olusegun Baiyewu, Adamu Girei Bakari, Sani B. Garko, Jibril Mohammed El-Bashir, Aishatu Maude Suleiman, Haruna Mohammed Muktar, Micheal A. Amedu · 2018 · Psychogeriatrics
17. Unveiling the mechanistic nexus: how micronutrient enrichment shapes brain function, and cognitive health
    Siddhartha Das, Pradipta Banerjee, Sudipta Jana, Hemanshu Mondal · 2025 · Frontiers in Molecular Biosciences
18. Synthetic PPAR Agonist DTMB Alleviates Alzheimer's Disease Pathology by Inhibition of Chronic Microglial Inflammation in 5xFAD Mice
    Eun-Ji Oh, Jeong-hwa Kang, Kyung Won Jo, Won-Sik Shin, Young-Hun Jeong, Byunghee Kang, Tae-Young Rho, So Yeon Jeon, Jihoon Lee, Im‐Sook Song et al. · 2022 · Neurotherapeutics
19. The association between blood lipids and cognitive impairment in type 2 diabetes mellitus
    Li Ma, Yuexing Yuan, Feng-Jin Cheng, Yan Liu, Qiong Wei, You‐Fan Peng, Yao Wang · 2024 · European journal of medical research
20. Microalgae and cyanobacteria as natural sources of antioxidant enzymes and enzyme inhibitors for Alzheimer's and diabetes
    Kilian Odenthal, Emmanuel Borges Nunes, Nuno Nunes, Tomásia Fernandes, Igor A. Fernandes, Miguel Â. A. Pinheiro de Carvalho · 2024 · Algal Research
21. Ameliorating effect of anti-Alzheimer’s drugs on the bidirectional association between type 2 diabetes mellitus and Alzheimer’s disease
    Amira Saber Ahmed, Rehab M. Elgharabawy, Amal Hassan Al-Najjar · 2017 · Experimental Biology and Medicine
22. Resting-state functional MR imaging shed insights into the brain of diabetes
    Yun Fei Wang, Xue Man Ji, Guangming Lu, Long Jiang Zhang · 2016 · Metabolic Brain Disease
23. Association between DNA methylation of SORL1 5′-flanking region and mild cognitive impairment in type 2 diabetes mellitus
    Yang Yu, Wang Mingjiao, Xiao‐Hui Yang, Miao Sui, Tao� Zhang, Jin Liang, Xinyi Gu, Xiaomei Wang · 2016 · Annales d Endocrinologie
24. Ghrelin is a possible new predictor associated with executive function in patients with type 2 diabetes mellitus
    Siting Chen, Zuo Xuyang, Yuan Li, Tian Jiang, Nan Zhang, Fang Dai, Qiaoer Chen, Qiu Zhang · 2016 · Journal of Diabetes Investigation
25. Is diabetes associated with increased pathological burden in Alzheimer's disease?
    Kaviyon Sadrolashrafi, Suzanne Craft, Boris Decourt, Abdu Adem, Jeffrey R. Wilson, Justin Miller, Marwan Noel Sabbagh · 2021 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
26. Elucidating the multi-targeted anti-amyloid activity and enhanced islet amyloid polypeptide binding of β-wrapins
    Asuka A. Orr, Hamed Shaykhalishahi, Ewa A. Mirecka, Sai Vamshi R. Jonnalagadda, Wolfgang Hoyer, Phanourios Tamamis · 2018 · Computers & Chemical Engineering
27. Regulation of Adipogenesis and Lipid Deposits by Collapsin Response Mediator Protein 2
    Yih-Hsin Chang, Jen‐Ning Tsai, Shu-Wen Chang, Wei-Ting Hsu, Ching‐Ping Yang, Chiao‐Wan Hsiao, Ming‐Yuh Shiau · 2020 · International Journal of Molecular Sciences
28. Evaluation of Amyloid Polypeptide Aggregation Inhibition and Disaggregation Activity of A-Type Procyanidins
    Taisei Tanaka, Vipul V. Betkekar, Ken Ohmori, Keisuke Suzuki, Hideyuki Shigemori · 2021 · Pharmaceuticals
29. Disease–disease interactions: molecular links of neurodegenerative diseases with cancer, viral infections, and type 2 diabetes
    Yuxi Lin, Je Min Yoo, Danni Li, Yunseok Heo, Masaki Okumura, Hyung‐Sik Won, Michele Vendruscolo, Mi Hee Lim, Young‐Ho Lee · 2025 · Translational Neurodegeneration
30. Dissociation between Conceptual and Perceptual Implicit Memory: Evidence from Patients with Frontal and Occipital Lobe Lesions
    Liang Gong, Jihua Wang, Xudong Yang, Lei Feng, Xiu Li, Cui Gu, Meihong Wang, JiaYun Hu, Huaidong Cheng · 2016 · Frontiers in Human Neuroscience
31. Beyond CSF and Neuroimaging Assessment: Evaluating Plasma miR-145-5p as a Potential Biomarker for Mild Cognitive Impairment and Alzheimer’s Disease
    Qingfeng Wen, Mandy Melissa Jane Wittens, Sebastiaan Engelborghs, Marcel H. M. van Herwijnen, Maria Tsamou, Erwin Roggen, Hubert J.M. Smeets, Julian Krauskopf, Jacob J. Briedé · 2024 · ACS Chemical Neuroscience
32. Inhibitory activities of phenylpropanoids from Lycopus lucidus on amyloid aggregation related to Alzheimer’s disease and type 2 diabetes
    Jiayi Sun, Toshihiro Murata, Hideyuki Shigemori · 2020 · Journal of Natural Medicines
33. Hypoglycemia, Vascular Disease and Cognitive Dysfunction in Diabetes: Insights from Text Mining-Based Reconstruction and Bioinformatics Analysis of the Gene Networks
    Olga Vladimirovna Saik, Vadim Valer'evich Klimontov · 2021 · International Journal of Molecular Sciences
34. Peripheral Blood Biomarkers Coupled with the Apolipoprotein E4 Genotype Are Strongly Associated with Semantic and Episodic Memory Impairments in Elderly Subjects with Amnestic Mild Cognitive Impairment and Alzheimer’s Disease
    Supasitthumrong, Thitiporn, Tunvirachaisakul, Chavit, Aniwattanapong, Daruj, Tangwongchai, Sookjaroen, Chuchuen, Phenphichcha, Tawankanjanachot, Itthipol, Snabboon, Thiti, Hemrungrojn, Solaphat, Carvalho, Andre F., Maes, Michael · 2019 · Journal of Alzheimer’s Disease
35. Outcomes and healthcare resource utilization associated with medically attended hypoglycemia in older patients with type 2 diabetes initiating basal insulin in a US managed care setting
    Javier Escalada, Laura Liao, Chunshen Pan, Hongwei Wang, MEHMET MURAT BALA · 2016 · Current Medical Research and Opinion
36. The inefficacy of donepezil on glycated-AChE inhibition: Binding affinity, complex stability and mechanism
    Reza Yekta, Leila Sadeghi, Gholamreza Dehghan · 2020 · International Journal of Biological Macromolecules
37. Case report: Ketogenic diet acutely improves cognitive function in patient with Down syndrome and Alzheimer’s disease
    Annette Bosworth, Vyvyane Loh, Blackjack N. Stranahan, Christopher Palmer · 2023 · Frontiers in Psychiatry
38. Nanomedicine-Driven Therapeutic Interventions of Autophagy and Stem Cells in The Management of Alzheimer’s Disease
    Fahad Saad Alhodieb, Mohammad Akhlaquer Rahman, Muhammad Abul Barkat, Abdulkareem Ali Alanezi, Harshita Abul Barkat, Hazrina Ab. Hadi, Ranjit Kumar Harwansh, Vineet Mittal · 2023 · Nanomedicine
39. Anti-apoptotic and antioxidant effects of low dose gamma irradiation against diabetes-induced brain injury in rats
    Engy Refaat Rashed, M El-Daly, Sawsan A. Abd elhalim, Mona A. El‐Ghazaly · 2016 · Radiation and Environmental Biophysics
40. Common Pathological Mechanisms and Risk Factors for Alzheimer’s Disease and Type-2 Diabetes: Focus on Inflammation
    Emmanuel Moyse, Mohamed Haddad, Camélia Benlabiod, Charles Ramassamy, Slavica M Krantic · 2019 · Current Alzheimer Research
41. Palm Fruit Bioactives augment expression of Tyrosine Hydroxylase in the Nile Grass Rat basal ganglia and alter the colonic microbiome
    Robert P. Weinberg, Vera V. Koledova, Avinaash Subramaniam, Kirsten Schneider, Anastasia Artamonova, Ravigadevi Sambanthamurthi, K. C. Hayes, Anthony J. Sinskey, ChoKyun Rha · 2019 · Scientific Reports
42. MRI Metrics of Cerebral Endothelial Cell–Derived Exosomes for the Treatment of Cognitive Dysfunction Induced in Aging Rats Subjected to Type 2 Diabetes
    Guangliang Ding, Lian Li, Li Zhang, Michael Chopp, Esmaeil Davoodi‐Bojd, Qingjiang Li, Chao Li, Min Wei, Zhenggang Zhang, Quan Jiang · 2022 · Diabetes
43. The effects of long-term cumulative HbA1c exposure on the development and onset time of dementia in the patients with type 2 diabetes mellitus: Hospital based retrospective study (2005–2021)
    Sunyoung Cho, Choon Ok Kim, Bong Soo, Eosu Kim, Chung Mo Nam, Min‐Gul Kim, Min Soo Park · 2023 · Diabetes Research and Clinical Practice
44. Antioxidant, α-amylase and acetylcholinesterase inhibitory potential of Mazus pumilus (Japanese Mazus) extract: An in-vitro and in-silico study
    Saheem Ahmad, Sultan Alouffi, Uzma Shahab, Naif Kandash Binsaleh, Mohamed E. Ghoniem, Rihab Akasha, Mohammad Kaleem Ahmad, Naved Ahmad, Mohd Waiz, M. Salman Khan · 2023 · Arabian Journal of Chemistry
45. Comorbidity Genes of Alzheimer’s Disease and Type 2 Diabetes Associated with Memory and Cognitive Function
    Seong Beom Cho · 2024 · International Journal of Molecular Sciences
46. Proteomic Investigation of Murine Neuronal α7-Nicotinic Acetylcholine Receptor Interacting Proteins
    Matthew J. Mulcahy, João A. Paulo, Edward Hawrot · 2018 · Journal of Proteome Research
47. Amylin and pramlintide modulate γ-secretase level and APP processing in lipid rafts
    Youssef M. Mousa, Ihab M. Abdallah, Misako Hwang, Douglas R. Martin, Amal Kaddoumi · 2020 · Scientific Reports
48. Evaluating the Role of Hormone Therapy in Postmenopausal Women with Alzheimer’s Disease
    Jelena Osmanović Barilar, Melita Šalković‐Petrišić · 2016 · Drugs & Aging
49. In newly diagnosed diabetes, hyperglycemia is associated with increased brain iron deposition, measured by MRI-based Quantitative Susceptibility Mapping (QSM)
    Maria Agnese Pirozzi, Fabrizio Esposito, Francesca Trojsi, Carla Passaniti, Irene Di Meo, Maria Chiara Auriemma, Antonella Chianese, Michele Cerasuolo, Giuseppe Paolisso, Mario Cirillo et al. · 2025 · Journal of Advanced Research
50. Flavonols as a Potential Pharmacological Intervention for Alleviating Cognitive Decline in Diabetes: Evidence from Preclinical Studies
    Anđela Horvat, Ignacija Vlašić, Jasminka Štefulj, Nada Oršolić, Maja Jazvinšćak Jembrek · 2023 · Life
51. Unlocking the possibilities of therapeutic potential of silymarin and silibinin against neurodegenerative Diseases-A mechanistic overview
    Sumel Ashique, Sourav Mohanto, Nitish Kumar, Sagnik Nag, Anuradha Mishra, Aritra Biswas, Mohd Rihan, Shriyansh Srivastava, Mithun Bhowmick, Farzad Taghizadeh‐Hesary · 2024 · European Journal of Pharmacology
52. Effect of Passage Number and Culture Time on the Expression and Activity of Insulin-Degrading Enzyme in Caco-2 Cells
    Taiebeh Mohammadi Farsani, Elahe Motevaseli, Nadia Neyazi, Mohammad Reza Khorramizadeh, Elaheh Zafarvahedian, Mohammad Hossein Ghahremani · 2018 · PubMed Central
53. PKR modulates abnormal brain signaling in experimental obesity
    Mariko F. Taga, François Mouton‐Liger, Malha Sadoune, Sarah Gourmaud, Jenny Norman, Marion Tible, Sylvie Thomasseau, Claire Paquet, James A. R. Nicoll, Delphine Boche et al. · 2018 · PLoS ONE
54. The Effect of Type 2 Diabetes Mellitus on Neuropsychological Symptoms in Chinese Early Alzheimer’s Disease Population
    Qianqian Shi, Faying Zhou, Mei Jing, Haimei Yang, Hui-Yun Li · 2020 · Neuropsychiatric Disease and Treatment
55. Sesamin suppresses advanced glycation end products induced microglial reactivity using BV2 microglial cell line as a model
    Sasimol Udomruk, Benjawan Wudtiwai, Thuzar Hla Shwe, Thanyaluck Phitak, Peraphan Pothacharoen, Mattabhorn Phimphilai, Prachya Kongtawelert · 2021 · Brain Research Bulletin
56. Decrypting the Possible Mechanistic Role of Fenofibrate in Alzheimer's Disease and Type 2 Diabetes: The Truth and Mystery
    Mansour Abdulaziz Alsaleem, Hayder Mutter Al-Kuraishy, Ali Ismail Al-Gareeb, Maha M. Abdel‐Fattah, Mohammed Alrouji, Nasser A. Al‐Harchan, Mubarak Alruwaili, Marios Papadakis, Athanasios T. Alexiou, Gaber El‐Saber Batiha · 2025 · Journal of Cellular and Molecular Medicine
57. Polygenic score analysis identifies distinct genetic risk profiles in Alzheimer’s disease comorbidities
    Carlos F. Hernández, Camilo Villamán, Costin Leu, Dennis Lal, Ignacio Fernandez Mata, Andrés D. Klein, Eduardo Pérez‐Palma · 2025 · Scientific Reports
58. Cardiovascular Risk Factors, Alzheimer’s Disease, and the MIND Diet: A Narrative Review from Molecular Mechanisms to Clinical Outcomes
    Amirhossein Ataei Kachouei, Saiful Singar, Amber Wood, Jason D. Flatt, Sara K. Rosenkranz, Richard R. Rosenkranz, Neda Sara Akhavan · 2025 · Nutrients
59. Insights on the pathogenesis of type 2 diabetes as revealed by signature genomic classifiers in an African American population in the Washington, DC area
    Tanmoy Mondal, Christopher A. Loffredo, Jyothirmai J. Simhadri, Gail Nunlee‐Bland, Brent A. Korba, Jheannelle Johnson, Sharleine T. Cotin, Gemeyel Moses, Ruth I. Quartey, Charles D. Howell et al. · 2022 · Diabetes/Metabolism Research and Reviews
60. Effects of GABAB receptor activation on spatial cognitive function and hippocampal neurones in rat models of type 2 diabetes mellitus
    Xiaojun Cai, Lei Wang, Chunmei Hu · 2017 · Bioscience Reports · Retracted
61. Repositioning of antidiabetic drugs for Alzheimer’s disease: possibility of Wnt signaling modulation by targeting LRP6 an in silico based study
    Suman Manandhar, Keerthi Priya, Chetan Hasmukh Mehta, Usha Y. Nayak, Shama Prasada Kabekkodu, Karkala Sreedhara Ranganath Pai · 2021 · Journal of Biomolecular Structure and Dynamics
62. Neuroprotective effects of empagliflozin against scopolamine-induced memory impairment and oxidative stress in rats
    Mahdieh Anoush, Neda Taghaddosi, Zahra Bokaii Hosseini, Fatemeh Rahmati, Soroush Bijani, Ali Kalantari‐Hesari, Mir‐Jamal Hosseini · 2025 · IBRO Neuroscience Reports
63. Nano‐Chaperones: Bridging Therapeutics for Amyloid Aggregation in Alzheimer's Disease and Type‐2 Diabetes Mellitus
    Faiza Siddiqui, Pooja Mishra, Sheeba Khanam, Sachin Ranjan, Pravej Alam, Thamer Albalawi, Salman Khan, Snober Shabnam Mir · 2025 · European Journal of Neuroscience
64. Mechanisms underlying large-leaf yellow tea mediated inhibition of cognitive impairment in the 5xFAD model of Alzheimer's disease
    Xiaoyu Tang, Zhipeng Kan, Na Li, Jinbao Huang, Jinsong Zhang, Henry J. Thompson, Feng Gao, Yong Shen, Liang Zhang, Zhongwen Xie et al. · 2023 · Phytomedicine
65. The identification of biomarkers for Alzheimer's disease using a systems biology approach based on lncRNA-circRNA-miRNA-mRNA ceRNA networks
    Babak Sokouti · 2024 · Computers in Biology and Medicine
66. Word-stem priming and recognition in type 2 diabetes mellitus, Alzheimer’s disease patients and healthy older adults
    Maria Redondo, José Luís Beltrán-Brotóns, José Manuel Reales Avilés, Soledad Ballesteros · 2015 · Experimental Brain Research
67. Metabolic parameters and cognitive function in a cohort of older diabetic patients
    Anna Marie Herghelegiu, Raluca Mihaela Nacu, Gabriel Ioan Prada · 2016 · Aging Clinical and Experimental Research
68. The Glucagon Receptor Is Expressed in the Frontal Cortex and Impaired Signaling Associates With Cognitive Decline
    Sasha A. S. Kjeldsen, Jonas Folke, Maud Eline Ottenheijm, Marie Winther‐Sørensen, Jónvá Hentze, Pia Nyeng, Sara Luis García, Agata Casado-Sainz, Sanne Simone Kaalund, Reidar Albrechtsen et al. · 2025 · Journal of the Endocrine Society
69. Decoding the genetic relationship between Alzheimer’s disease and type 2 diabetes: potential risk variants and future direction for North Africa
    Wided Boukhalfa, Haifa Jmel, Nadia Kheriji, Ismail Gouiza, Hamza Dallali, Mariem Hechmi, Rym Kéfi · 2023 · Frontiers in Aging Neuroscience
70. Predicting Alzheimer's Disease Onset
    Harold I. Zeliger · 2019 · European Journal of Medical and Health Sciences
71. Discovery of Azaindolin-2-One as a Dual Inhibitor of GSK3β and Tau Aggregation with Potential Neuroprotective Activity
    Taha F. S. Ali, Halil I. Ciftci, Mohamed O. Radwan, Eslam Roshdy, Ahmed M. Shawky, Mohammed A. S. Abourehab, Hiroshi Tateishi, Masami Otsuka, Mikako Fujita · 2022 · Pharmaceuticals
72. Correlations between Cognitive Evaluation and Metabolic Syndrome
    Andrei Cătălin Oprescu, Cristina Grosu, Walther Bild · 2023 · Metabolites
73. Redox-active phytoconstituents ameliorate cell damage and inflammation in rat hippocampal neurons exposed to hyperglycemia+Aβ1-42 peptide
    Zübeyir Elmazoğlu, Sonia Galván‐Arzate, Michael Aschner, Edgar Rangel‐López, Oğuz Bayraktar, Abel Santamarı́a, Çi̇men Karasu · 2021 · Neurochemistry International
74. Diabetes: A risk factor for poor mental health in aging population
    AparajitBallav Dey, Rishav Bansal, Prasun Chatterjee, Avinash Chakrawarty, Sujata Satpathy, Nand Kishor Kumar, SadaNand Dwivedi · 2018 · Journal of Geriatric Mental Health
75. Insulin resistance as a mediator of physical activity's effects on beta-amyloid accumulation and tau phosphorylation: A scoping review
    Michael G Slee, Joanne Scotney, Stephanie Ruth Rainey‐Smith, Kirk I. Erickson, Hamid Reza Sohrabi, Giuseppe Verdile, Belinda M. Brown · 2025 · Ageing Research Reviews
76. Metformin provides superior neuroprotective potential compared to semaglutide in preventing diabetes-associated Alzheimer’s disease via dual actions
    Andrea N. Georgiou, Panos Zanos, Anna Onisiforou · 2026 · Communications Medicine
77. “Vitaction” deficiency: a possible root cause for multiple lifestyle disorders including Alzheimer’s disease
    Milind Watve, Ashwini Keskar Sardeshmukh · 2024 · Exploration of Neuroprotective Therapy
78. Causal Association Between Type 2 Diabetes Mellitus and Alzheimer’s Disease: A Two-Sample Mendelian Randomization Study
    Cong Li, Haifeng Qian, Lina Feng, Mingquan Li · 2024 · Journal of Alzheimer s Disease Reports
79. Factors Contributing of Ageing: Factors in Ageing
    Smita Pandey · 2018 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
80. Reassessing Diabetes and APOE Genotype as Potential Interacting Risk Factors for Alzheimer’s Disease
    Kaushik Ravipati, Yunxiao Chen, Joseph R. Manns · 2022 · American Journal of Alzheimer s Disease & Other Dementias®
81. Prodromal Glutamatergic Modulation with Riluzole Impacts Glucose Homeostasis and Spatial Cognition in Alzheimer’s Disease Mice
    Caleigh A. Findley, Samuel McFadden, MaKayla F. Cox, Lindsey N. Sime, Mackenzie R. Peck, Kathleen Quinn, Andrzej Bartke, Kevin N. Hascup, Erin R. Hascup · 2023 · Journal of Alzheimer s Disease
82. Role of the Genus Cinnamomum in the Management of Neurodegenerative Diseases: Outcomes and Shortcomings
    Ravinder Kaur, Richa Shri · 2018 · Indian Journal of Pharmaceutical Sciences
83. Cell Kinetics in the Adult Neurogenic Niche and Impact of Diet-Induced Accelerated Aging
    Alexander J. Stankiewicz, Farzad Mortazavi, Peter V. Kharchenko, Erin McGowan, Vasili A. Kharchenko, Irina V. Zhdanova · 2019 · Journal of Neuroscience
84. Effects of Familial Alzheimer’s Disease Mutations on the Folding Free Energy and Dipole–Dipole Interactions of the Amyloid β-Peptide
    Darcy S. Davidson, Joshua A. Kraus, Julia M. Montgomery, Justin A. Lemkul · 2022 · The Journal of Physical Chemistry B
85. Keynote Lecture
    Reniers, Peter, Leontjevas, Ruslan, Stoyanov, Slavi, Inge A. H. Knippenberg, Jacques J. D. M. van Lankveld, Debby L. Gerritsen · 2019 · International Psychogeriatrics
86. Prevalence and Determinants of Cognitive Impairment: A Study from Punjab, North India
    Neha Yadav, Vineet Chaudhary, Kallur Nava Saraswathy, Naorem Kiranmala Devi · 2025 · Neurology India
87. Activation of mitophagy improves cognitive dysfunction in diabetic mice with recurrent non-severe hypoglycemia
    Kejun Wu, Cuihua Huang, Wenrong Zheng, Yubin Wu, Qintao Huang, Menghua Lin, Ruonan Gao, Liqin Qi, Guanlian He, Xiaoying Liu et al. · 2023 · Molecular and Cellular Endocrinology
88. Effect of astaxanthin in type-2 diabetes -induced APPxhQC transgenic and NTG mice
    Joshua Adekunle Babalola, Anika Stracke, Tina Loeffler, Irene Schilcher, Spyridon Sideromenos, Stefanie Flunkert, Joerg Neddens, Åke Lignell, Manuela Prokesch, Ute Pazenboeck et al. · 2024 · Molecular Metabolism
89. Exploring Astrodaucus orientalis (L.) Drude: Phytochemical Analysis and its Biological Potential Against Alzheimer's and Diabetes
    Hafize Yuca, Bilge Aydın, Songül Karakaya, Gamze Göğer, Zeynebe Bingöl, Ayşe Civas, Mehmet Koca, Betül Demırcı, Oksana Sytar, İlhami Gülçın et al. · 2023 · Chemistry & Biodiversity
90. Inferring a directed acyclic graph of phenotypes from GWAS summary statistics
    Rachel Zilinskas, Chunlin Li, Xiaotong Shen, Wei Pan, Tianzhong Yang · 2024 · Biometrics
91. The “Hit and Run” Hypothesis for Alzheimer’s Disease Pathogenesis
    Tal Ganz, Tamir Ben‐Hur · 2024 · International Journal of Molecular Sciences
92. Evidence for the Control of Aggrecanases by Insulin and Glucose in Alzheimer's Disease
    Sümeyya Akyol, Veli Uğurcu, Özlem Çakmak, Aynur Altuntaş, Yunus Yükselten, Ömer Akyol, Asuman Sunguroğlu, Kadir Demircan · 2014 · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology
93. PTEROCARPUS MARSUPIUM HEARTWOOD EXTRACT RESTORES LEARNING, MEMORY AND COGNITIVE FLEXIBILITY IN A STZ-NA INDUCED DIABETES ANIMAL MODEL
    Bheemesh Vangalapati, Poornima Manjrekar, Anupama Hegde, Amith Kumar · 2016 · International Journal of Pharmacy and Pharmaceutical Sciences
94. The Diabetic Brain and Dementia
    K. A. Jellinger · 2015 · Journal of Alzheimer’s Disease & Parkinsonism
95. Neuroinflammatory Biomarkers in Diabetic Encephalopathy: Linking Cholinergic and Cognitive Dysfunction
    Tosin Abiola Olasehinde, Sunday I. Oyeleye, Ademola Olufolahan Olaniran, Md. Shahidul Islam · 2022 · Biomarkers in disease
96. JNK1 and JNK3: divergent functions in hippocampal metabolic-cognitive function
    Oriol Busquets, Triana Espinosa-Jiménez, Miren Ettcheto, Jordi Olloquequi, Mònica Bulló, Eva Carro, José Luis Cantero, Gemma Casadesús, Jaume Folch, Ester Verdaguer et al. · 2022 · Molecular Medicine
97. Comorbidities
    Irina I. Alafuzoff, Gábor Géza Kovács · 2017 · Handbook of clinical neurology
98. Assessment procedures including comprehensive geriatric assessment
    Willy Marcos Valencia, Marie Danet‐Lamasou, Hermes J. Florez, Isabelle Bourdel‐Marchasson · 2017 · Wiley eBooks
99. Insulin resistance and the metabolic syndrome
    Andrew J. Krentz, Angelo Scuteri · 2017 · Wiley eBooks
100. Role of peroxisome proliferator-activated receptor alpha in neurodegenerative diseases and other neurological disorders: Clinical application prospects
     Zijun Wu, Yuying Zhao, Shujing Hao, Mengyao An, Chengcheng Song, Jing Li · 2025 · Neural Regeneration Research